Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
about
Bipolar disorder and mechanisms of action of mood stabilizersArachidonic acid and the brainManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerLithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascadeDecrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeksDietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortexBipolar disorder: candidate drug targets.Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse modelsAltered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsEffectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model.Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjectsChronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorderPreliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disordersEvidence for a role of the arachidonic acid cascade in affective disorders: a review.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.COX-2 inhibitors as adjunctive therapy in schizophrenia.Fifteen weeks of dietary n-3 polyunsaturated fatty acid deprivation increase turnover of n-6 docosapentaenoic acid in rat-brain phospholipids.Mood stabilizer psychopharmacologyBrain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and diseaseImaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomographyGabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brainTranslational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorderAltered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient miceModulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support.The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids.Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brainImaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice
P2860
Q22252332-03B3F641-E1AE-487E-B950-F0923EACE5D3Q24620380-A10F428D-87F6-47F7-8714-41DEBC5630D1Q26777966-5BEF5506-8243-4EFB-9558-DC9B021FB1F5Q26850084-4F73382E-21CB-479E-8D39-E4D23AACFC06Q28578836-F106031B-14CB-43A6-B2A1-BB84A92A2182Q28581107-3AD01112-56D2-4BCA-A77D-F9D01DA0B987Q28751133-F8E387BF-A928-40CB-8716-01FED778ECF2Q30499792-C9AB3A8F-AA61-48EA-8D28-3B037A57CFEEQ31010610-5A67EB6F-08F3-409A-8A34-FB725B96375EQ33637566-F0B14822-7870-44A6-937C-913FD52B5080Q33664124-6604073B-C682-4759-AD45-0A390A09D78BQ33929918-A12A2C4F-112F-4651-B71B-256BC4FDC053Q34384181-8D39BA51-D3E2-4AAC-B7E6-C0F2D9F3E803Q34762525-AA28AF3F-29EA-49AA-BFF3-53DFBF107753Q34947046-36DAD47B-8B16-4B9C-AB23-269B2A63589AQ35076884-0FE213D2-DFED-41AA-A1D9-655714BF66DCQ35224308-50399A02-32B2-4B11-84BD-5E1083C1C4C0Q35284832-81AEFC71-6C07-47CC-A78B-3ABA24BB3F5CQ35476477-F56A6ABB-3C5D-4E51-BFB2-19685ED6D55AQ35496330-589A476B-BC9E-4329-A1D5-34AE77BC5A95Q35684403-622F1EF5-A029-4DF2-8BA8-8C4A43DAF5AEQ35770186-40DF3B37-B044-4FE2-940B-9816B715E44DQ35794579-39018104-CAE4-4968-B9A6-395289B6CB1EQ35842551-E3962BF1-EAAB-4161-8283-4200EA90A6B0Q35946492-4BC709FD-C2C0-40CF-98E3-FEE201D30E90Q36031634-6E2C9530-68D7-41D5-95C1-CF58D6EA8865Q36076753-2B60693B-2BAE-4A73-BEC3-DCB7A0585217Q36088214-676A2B78-2190-409B-BAB3-E2964CBCC046Q36199755-21F4E9C6-8617-4225-97AF-8D76CB294EB0Q36217965-F7C08CEC-AD83-4647-9F89-D70D50633BCDQ36253556-3106C89A-E564-44FE-A7E6-9E9602ABA2D8Q36306413-CBC055FD-40CC-42F0-9624-46E1D90E67DEQ36402957-E78679BD-0529-4686-889A-907AC5DA229DQ36518167-112C6CEC-E20F-46A3-8FDE-EFC96BA5216EQ36673587-D2B4EDA6-FA2C-4F9B-AFAB-CCBABA0D2C30Q36711212-1EB6AF80-A125-4738-84AA-C04DE581D71AQ36715129-DCEEC8A3-71EB-447E-B8F7-5F0DAF7A4234Q37077987-95425508-9513-4D65-BFD2-9190CC9124AFQ37178269-6901FCF9-C2FF-4561-A97D-F383E572F2DBQ37237548-E82B82E1-D5F5-4673-8FA5-50A24220C6CC
P2860
Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@ast
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@en
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@nl
type
label
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@ast
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@en
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@nl
prefLabel
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@ast
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@en
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@nl
P1433
P1476
Do lithium and anticonvulsants ...... d cascade in bipolar disorder?
@en
P2093
Francesca Bosetti
P304
P356
10.1001/ARCHPSYC.59.7.592
P407
P577
2002-07-01T00:00:00Z